References

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2024 · External reference

Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma

10.1002/bjs.10597 · 2017 · External reference

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): A randomised, open-label, multicentre, phase 3 trial

10.1016/s0140-6736(23)01796-8 · 2023 · External reference

BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update

10.1016/j.jhep.2025.10.020 · 2026 · External reference

Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: A Japanese multicenter study

10.1007/s00595-024-02930-x · 2025 · External reference

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

10.1097/hep.0000000000000466 · 2023 · External reference

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

10.1016/j.jhep.2025.03.033 · 2025 · External reference

Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade

10.1200/jco.2014.57.9151 · 2015 · External reference

Emerging prognostic markers in patients undergoing liver resection for hepatocellular carcinoma: A narrative review

10.3390/cancers16122183 · 2024 · External reference

Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma

10.1016/j.hpb.2021.06.414 · 2022 · External reference

The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy

10.1002/ags3.12637 · 2022 · External reference

Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy

2024 · External reference

Integrating inflammation, nutrition, and immunity: the CALLY index as a prognostic tool in digestive system cancers - a systematic review and meta-analysis

10.1186/s12885-025-14074-3 · 2025 · External reference

Prognostic impact of the CALLY index in patients with resectable pancreatic cancer

10.1016/j.soi.2024.100119 · 2025 · External reference

The EZ-ALBI score as a prognostic tool for outcomes after resection of small hepatocellular carcinoma (</=3 cm

10.1111/hepr.14210 · 2025 · External reference

The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system

10.1038/s41598-025-03985-7 · 2025 · External reference

Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma

10.1002/ags3.12286 · 2019 · External reference

Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma

10.1002/ags3.12686 · 2023 · External reference

Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma

10.1111/jgh.13250 · 2016 · External reference

The prognostic impact of perioperative dynamic changes in cachexia index in patients with hepatocellular carcinoma

10.1002/ags3.12804 · 2024 · External reference

Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy

10.1007/s00595-021-02427-x · 2022 · External reference

Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy

10.1038/s41423-025-01308-4 · 2025 · External reference

Intrahepatic recurrence of hepatocellular carcinoma after resection: an update

10.1007/s12328-021-01394-7 · 2021 · External reference

A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy

10.1016/j.hpb.2017.06.002 · 2017 · External reference

The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful predictor of postoperative complications in patients with a colonic stent for obstructive colorectal cancer: A Japanese multicenter study

10.1007/s00595-024-02924-9 · 2025 · External reference